直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Hatch-Waxman and Follow-On Biologics: Strategies for Protecting Your Innovative Products

October 6, 2011

Cambridge, MA

Effective and cost-efficient legal guidance now, more than ever, is essential for the protection of innovator small molecule and biologic pharmaceutical products. During this program our panelists will discuss:

• An Overview of the Follow-On Biologics Framework 

• Strategies for Successfully Litigating Hatch-Waxman and Biosimilar Cases 

• Strategies for Maximizing Small Molecule and Biosimilar Patent Protection

Where:

Finnegan

55 Cambridge Parkway

Cambridge, MA 02142

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

生物藥品

Related Offices

Boston, MA

Related Insights

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Ruling in Hatch-Waxman Litigation Based on Claim Construction, Prosecution History Estoppel, and the Disclosure-Dedication Rule

June 26, 2026

Federal Circuit IP Blog

Redesigns Done Right at the ITC: Federal Circuit Affirms ITC Determination of Noninfringement of Redesigned Products

June 26, 2026

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Lecture

Latest Developments in U.S. Section 337 Investigations and Response Strategies

June 12, 2026

Dongguan

European IP Blog

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

8 June 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Conference

BIA Start-up Festival

May 21, 2026

London

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP